PT Dosni Roha Indonesia Tbk (ISX:ZBRA) Valuation Rank

View and export this data going back to 1991. Start your Free Trial

What is PT Dosni Roha Indonesia Tbk Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

PT Dosni Roha Indonesia Tbk Valuation Rank Related Terms

Thank you for viewing the detailed overview of PT Dosni Roha Indonesia Tbk's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Dosni Roha Indonesia Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Dosni Roha Indonesia Tbk (ISX:ZBRA) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Prof. Dr. Satrio, Blok C-4, No. 5, Satrio Tower Lt. 23, Kuningan Timur, Setiabudi, Jakarta Selatan, IDN, 12950

Website

https://www.dnr.id

PT Dosni Roha Indonesia Tbk through its subsidiaries, engages in trading, export-import, logistic, and information Technology (IT) business in Indonesia. The company operates through the segments of Logistics, Technology and Information, Medical Equipment Trade, and Others. It generates the majority of its revenue from the Medical Equipment Trade segment.